Report Store Get Proposal

Breakthrough Device Designation granted to the AI Software for CTEPH

Download

Share

Home Blog Fda alert breakthrough device designation granted to the artificial intelligence software for cteph

Breakthrough Device Designation granted to the AI Software for CTEPH

Dec 05, 2018

FDA

FDA

Downloads

Click Here To Get the Article in PDF

Recent Articles

LensGen’s Juvene Intraocular Lens; Nevro announces clinical data publications; FDA Clearance to I...

First Patient Enrolled in Kaizen Clinical Study in Japan; Koneksa’s At-Home Mobile Spirometry Cli...

FDA Approves Turalio; Sosei Heptares and Takeda Forge R&D Partnership

Sanofi’s Qfitlia Becomes First FDA-Approved Therapy for Hemophilia A or B; FDA Approves AstraZene...

FDA Approves PTC’s AADC Gene Therapy; DUPIXENT sBLA Acceptance for Urticaria; CHMP Recommen...

Downloads

Article in PDF

Recent Articles

Astellas & AviadoBio’s Exclusive Deal for AVB-101; GSK’s Depemokimab Shows Positive Res...

Moderna’s Phase III Trials for Dual Influenza and COVID-19 Vaccine; Almirall’s Klisyri FDA Approv...

Merck’s KEYTRUDA as Adjuvant Therapy for RCC Patients; BMS Receives Positive CHMP Opinion for CAR...

Edwards’ Sapien 3 with Alterra Prestent; Koios Medical’s breast, thyroid cancer-spotting AI; Line...

Medical Radiation Detection Devices: Essential Tools in Healthcare and Diagnostics

pharma-news-for-bayer-klotho-trethera

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Nanoscope’s MCO-010 Begins FDA Rolling Submission for Retinitis Pigmentosa; Bayer’s KERENDIA Approved by FDA for Heart Failure With Preserved Ejection Fraction; Klotho Neurosciences’ KLTO-202 Receives FDA Orphan Drug Designation for ALS; Trethera’s TRE-515 Granted FDA Fast Track Designation for Metastatic Prostate Cancer; Adcentrx’s ADRX-0405 Awarded FDA Orphan Drug Designation for Gastric Cancer

pharma-news-for-merck-kalvista-mustang

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Merck’s WINREVAIR Granted FDA Priority Review for Pulmonary Arterial Hypertension; KalVista’s EKTERLY Approved by FDA as First Oral On-Demand Therapy for Hereditary Angioedema; Fujifilm’s FF-10832 Receives FDA Orphan Drug Designation for Biliary Tract Cancer; Mustang Bio’s MB-101 Granted FDA Orphan Drug Designation for Glioblastoma and Astrocytomas; Denali’s Tividenofusp Alfa Accepted for FDA Priority Review for Hunter Syndrome

amniotic-membrane-market-regenerative-healthcare

Articles

How the Amniotic Membrane Market is Transforming Regenerative Healthcare Worldwide

artificial intelligence